Published in Drug Week, October 15th, 2010
firm focusing on protein mimicry technology for the generation of novel therapeutics, announced the establishment of a Scientific Advisory Board (SAB). The SAB will guide the company in the further development and application of its core protein mimicking technology for the creation of novel therapeutic peptide drugs and monoclonal antibodies.
The Scientific Advisory Board is chaired by Sir Gregory Winter, a scientific pioneer of protein engineering and therapeutic monoclonal antibodies. He invented techniques to make humanized and fully human antibodies for therapeutic uses. Winter co-founded...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.